<html><!-- #BeginTemplate "/Templates/news2001.dwt" -->
<head>
<!-- #BeginEditable "doctitle" -->
<!-- #BeginEditable "doctitle" -->
<title>Public Citizen</title>
<!-- #EndEditable -->
<!-- #EndEditable -->
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
</head>

<body text="#000000" link="#0000FF" bgcolor="#000099" vlink="#0000FF" alink="#0000FF">
<div align="center">
<center>
<table width="600" bgcolor="#FFFFFF" cellpadding="0" cellspacing="0" align="center">
<tr align="center" valign="top">
<td>
<table border="0" width="100%" cellspacing="0" cellpadding="0" align="center">
<tr valign="middle">
<td align="center" width="15" height="100">&nbsp;</td>
<td align="center" width="340" height="100"> 
                <p align="left"><a href="http://www.commondreams.org"><img border="0" src="../images/newswire.gif" width="340" height="75" alt="Common Dreams NewsCenter" align="bottom"></a> 
              </td>
              <td align="center" width="245" height="100"><a href="http://www.commondreams.org/special/feature.htm"><img src="../special/images/feature.gif" width="230" height="75" border="0"></a></td>
</tr>
<tr valign="middle" align="left" bgcolor="#F4F4E1">
<td height="25" width="15">&nbsp;</td>
              <td bgcolor="#F4F4E1" height="25" width="340"> 
                <p align="left"><b><font face="Arial, Helvetica, sans-serif" size="1">&nbsp;<a href="http://www.commondreams.org/">Home</a> 
                  | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                  |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                  Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                  </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                  | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                  | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                  </font><font color="#000000" size="1" face="Arial"> </font> 
              </td>
<td align="center" bgcolor="#F4F4E1" height="25" width="245"><font face="Arial, Helvetica, sans-serif" size="1" color="#000099">
<script>
var mydate=new Date()
var theYear=mydate.getFullYear()
var day=mydate.getDay()
var month=mydate.getMonth()
var daym=mydate.getDate()
if (daym<10)
daym="0"+daym
var dayarray=new Array("Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday")
var montharray=new Array("January","February","March","April","May","June","July","August","September","October","November","December")
document.write(dayarray[day]+", "+montharray[month]+" "+daym+", "+theYear)
</script>
</font></td>
</tr>
</table>
<table border="0" cellpadding="3" cellspacing="0" width="100%">
<tr bgcolor="#E8E8E8" align="right" valign="middle"> 
<td width="600" colspan="5" height="25"> 
     
<div align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b> 
<a href="http://www.commondreams.org/">Home</a> &gt; <a href="http://www.commondreams.org/community.htm">Progressive 
Community</a> &gt; <a href="http://www.commondreams.org/newswire.htm">NewsWire</a> 
</b></font><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&gt; 
For Immediate Release&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b></div>
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7"> <font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/wirearchive.htm">
</a></font> 
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font></p>
<p align="left">&nbsp;</p>
<p>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="bottom" align="left" bgcolor="#FFFFFF" width="90%">
<div align="right"><!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</div>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7">&nbsp; </td>
</tr>
<tr> 
<td valign="top" align="left" width="90%" bgcolor="#FFFFFF"><!-- #BeginEditable "Contact" -->
<div align="left">
<table width="100%" cellpadding="3">
<tr>
        
<td align="left" valign="top" width="200"><font size="2" face="Arial, Helvetica, sans-serif"><strong>FOR IMMEDIATE RELEASE<br>
         </strong>JULY 30, 
2001<br>
         6:22&nbsp;PM<strong><br>
         </strong></font></td>
<td align="left" valign="top" width="330"><font size="2" face="Arial, Helvetica, sans-serif"><b>CONTACT: </b> <b>&nbsp;<a href="http://www.citizen.org">Public Citizen</a><br>
         </b>
Booth Gunter (202) 588-7742 <br>
         </font>
</td>
</tr>
</table>
</div>
<!-- #EndEditable --></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><font size="4" face="Arial, Helvetica, sans-serif"><b><!-- #BeginEditable "Header" -->
<div align="center">Key Senate Committee to Debate Bill Giving Windfall Profits to Drug Makers;
Fails to Assure Safety of All Kids&#146; Drugs<br>
<font size="2">
Aug. 1 Is Senate Committee Markup of Bill That Would Cost Consumers $14 Billion</font></div>
<!-- #EndEditable --></b></font></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%">&nbsp; 
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="90%"><!-- #BeginEditable "Body" --><font face="Arial, Helvetica, sans-serif" size="2">WASHINGTON 
- July 30 - On Wednesday (Aug. 1), the Senate Health, Education, Labor and
Pensions Committee will take up legislation sponsored by Sens. Chris Dodd (D-Conn.) and
Mike DeWine (R-Ohio) that gives drug companies a six-month extension on their lucrative
monopoly patents just for testing the safety of such drugs in children. Dodd&#146;s
legislation, however, fails to assure that <i>all</i> drugs likely to be used in children
will be tested for safety prior to marketing.</font>
<p><font face="Arial, Helvetica, sans-serif" size="2">Monopoly extensions first were made available to drug companies in exchange for testing
in children by legislation sponsored by Dodd and enacted in 1997. The new legislation
&#150; the &quot;Best Pharmaceuticals for Children Act,&quot; S. 838 &#150; would continue
the practice of granting what is known as &quot;pediatric exclusivity&quot; to the drug
companies.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">Consumer advocates have been appealing to Dodd to address the higher costs for drugs
that his legislation would impose on already-overburdened consumers, particularly the
elderly. They also have asked Dodd to support changes to the bill that would assure that
all drugs likely to be used in children are first tested for safety.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">Pediatric exclusivity gives a windfall to the prescription drug industry. The U.S. Food
and Drug Administration (FDA) has estimated that the six months of pediatric exclusivity
that would be granted for hundreds of drugs over the next 20 years, as their patents
expire, would increase brand-name drug company sales by $29 billion. The cost to consumers
would be an additional $14 billion over that time because access to lower-priced generics
would be delayed six months. </font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">The profits enjoyed by the drug companies from the patent extensions greatly exceed the
cost of conducting the studies, a Public Citizen <a href="http://www.citizen.org/congress/drugs/pedexclusivityfactsheet.html" target="new">analysis</a>
shows. The FDA estimates that drug companies will reap $592 million in additional
annual profits under pediatric exclusivity. It also estimates that the annual cost of
conducting studies if they had been required between 1993 and 1997 was only $80 million.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">&quot;If senators want to assure that drugs are tested before they are given to
children, they should support legislation that requires this testing to be done as a
condition of FDA&#146;s approval of drugs,&quot; said Frank Clemente, director of Public
Citizen&#146;s Congress Watch. &quot;This would be the courageous approach. But it
requires the Senate to stand up to the drug industry. It is also the only solution that
puts the burden for the safety of drugs where it should be, squarely on the shoulders of
the drug industry, the most profitable industry in the nation, rather than on the backs of
consumers.&quot;</font>
</p>
<p ALIGN="JUSTIFY"><font face="Arial, Helvetica, sans-serif" size="2">In 2000, the 11 biggest brand name drug manufacturers made $28 billion
in profits, prompting <i>Fortune</i> magazine to once again rank the drug industry as the
most profitable in America. During the 1990s, the average profits of the Fortune 500 drug
companies have been three to four times the average profits of all Fortune 500 industries.
</font></p>

<p><font face="Arial, Helvetica, sans-serif" size="2">Among the key problems with the Dodd-DeWine bill:

</font>
<ul>
  
<li><font face="Arial, Helvetica, sans-serif" size="2">It fails to ensure that drugs likely to be prescribed to children will be tested in
    children before being prescribed for their use. Public Citizen analysis of FDA documents
    reveals that the current law, to which the Dodd bill makes only minor modifications, will
    leave many drugs important for children untested.</font></li>
</ul>
<ul>
  
<li><font face="Arial, Helvetica, sans-serif" size="2">It doesn&#146;t guarantee that companies will make the results of their studies known
    through the labeling changes necessary for drugs to be used safely and effectively in
    children.</font></li>
</ul>
<p><font face="Arial, Helvetica, sans-serif" size="2">In 1998, the FDA issued a rule that would require testing for all <u>new</u>
drugs that are likely to be used by &quot;a substantial number of children,&quot; or that
would provide &quot;meaningful therapeutic benefit&quot; to children. But enforcement of
the rule has been blocked by litigation.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">Public Citizen endorses the FDA&#146;s proposal and believes that pediatric exclusivity
for new drugs should be ended and that drug companies should be required to test new drugs
for use in children as a condition of getting FDA approval to market their product. For
drugs already on the market, Congress should give the FDA authority to require testing and
end the six months of additional patent protection.</font></p>
<p><font face="Arial, Helvetica, sans-serif" size="2">&quot;It&#146;s bad enough giving drug companies a huge windfall for something that
should be required as part of the FDA drug approval process,&quot; Clemente said.
&quot;What&#146;s worse is that after consumers pay out an extra $14 billion for pediatric
exclusivity, many of the drugs most needed by children will remain untested.</font></p>
<font FACE="Times New">
<p><font face="Arial, Helvetica, sans-serif" size="2">&quot;Some advocates for children support the pediatric exclusivity incentive out of
frustration and desperation, fearing that drug companies would conduct no pediatric tests
without a hefty financial reward. This attitude makes it easy for members of Congress to
support S. 838. Senators may see a vote for the Dodd-DeWine bill, which would continue the
handout to the industry, as a safe vote for children. But Senate Democrats need to use
their new-found clout to stop corporate welfare for the drug industry.&quot; </font>
<p align="center">###</p>
</font><!-- #EndEditable --></td>
</tr>
<tr> 
              <td valign="top" align="left" bgcolor="#FFFFFF" width="90%">
<!-- referralblast starts here -->
<a href="http://www.referralblast.com/cs/com/co1.asp" onclick="window.open('http://www.referralblast.com/cs/com/co1.asp?url=' + location.href,'comWnd','width=440,height=476,scrollbars=yes,menubar=no,resizable=yes'); return false;" target="_blank" onMouseOver="window.status='Send this page to a friend'; return true;" onMouseOut="window.status=''; return true;"><img src="../images/rn-spa-c.gif" alt="Send this page to a friend" width="118" height="23" border="0"></a> 
<!-- referralblast ends here -->
</td>
</tr>
<tr bgcolor="#E8E8E8"> 
<td valign="top" align="center" width="100%" colspan="5" height="15">

<div align="center"><small><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Common Dreams <a href="http://www.commondreams.org/">NewsCenter</a>&nbsp;is a non-profit news service<br>
 providing breaking news and views for the Progressive Community.</b></font></small> 
</div>
<p align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1"><small>The 
press release posted here has been provided to Common Dreams NewsWire by  
one of the many progressive organizations who make up <a href="http://www.commondreams.org/community.htm">America's Progressive Community</a>. 
If 
you wish to comment on this press release or would like more information, 
please contact the organization  directly.<br>
 
</small></font><font size="1" face="Arial">*all times Eastern US (GMT-5:00)</font><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font><font face="Arial, Helvetica, sans-serif" size="2"><small><br>
 <br>
</small><b><font size="4">Making News?</font></b><br>
                  Read our <a href="http://www.commondreams.org/newspolicy.htm">Guidelines 
                  for Submitting News Releases</a><br>
                  </font></p>
<div align="center">
<center>
                    <font face="Arial, Helvetica, sans-serif" size="3"><b><font face="Arial, Helvetica, sans-serif" size="1"><a href="http://www.commondreams.org/">Home</a> 
                    | <a href="http://www.commondreams.org/newswire.htm">Newswire</a> 
                    |&nbsp;<a href="http://www.commondreams.org/about.htm">About 
                    Us</a> | <a href="http://www.commondreams.org/donate.htm">Donate</a> 
                    </font></b><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> 
                    | <a href="http://www.commondreams.org/archives.htm">Archives</a></b></font><font color="#000000" size="1" face="Arial"> 
                    </font><font size="1" face="Arial, Helvetica, sans-serif"><b> 
                    </b></font></font><b><font face="Arial, Helvetica, sans-serif" size="2"><br>
</font></b>
</center>
</div>
<p>
<div align="center"><font face="Arial, Helvetica, sans-serif" size="2"><i>Tell Us What You Think:</i> 
 <a href="mailto:editor@commondreams.org">editor@commondreams.org 
</a><br>
 
</font> 
 


</div>
                <p align="center"> <font face="Arial, Helvetica, sans-serif" size="1">© Copyright 
                  1997-2003 Common Dreams.<br>
 www.commondreams.org</font></p>
                
<p>
               </td>
</tr>
</table>
</td>
</tr>
</table>

</center>
</div>
<p align="center">&nbsp;</p>
</body>

<!-- #EndTemplate --></html>
